These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
732 related articles for article (PubMed ID: 9185968)
1. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats. Myers NC; Andrews GA; Chard-Bergstrom C Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo). Andrews GA; Myers NC; Chard-Bergstrom C Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649 [TBL] [Abstract][Full Text] [Related]
3. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas? Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of pancreatic neuroendocrine tumor in Panthera tigris tigris. Nyska A; Goldstein J; Eshkar G; Klein B J Wildl Dis; 1996 Jul; 32(3):541-4. PubMed ID: 8827685 [TBL] [Abstract][Full Text] [Related]
5. Validation of a rapid solid-phase radioimmunoassay for canine, bovine, and equine insulin. Reimers TJ; Cowan RG; McCann JP; Ross MW Am J Vet Res; 1982 Jul; 43(7):1274-8. PubMed ID: 6285776 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic endocrine carcinoma with multiple hormone production in a raccoon (Procyon lotor). Yoshikawa K; Matsuura S; Tsuchiya T; Kadota K J Comp Pathol; 1999 Apr; 120(3):301-6. PubMed ID: 10213674 [TBL] [Abstract][Full Text] [Related]
8. Chromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cells. Cetin Y; Aunis D; Bader MF; Galindo E; Jörns A; Bargsten G; Grube D Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2360-4. PubMed ID: 8096340 [TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular characterization of a feline insulinoma. Jackson TC; Debey B; Lindbloom-Hawley S; Jones BT; Schermerhorn T J Vet Intern Med; 2009; 23(2):383-7. PubMed ID: 19192149 [TBL] [Abstract][Full Text] [Related]
10. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours. Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384 [TBL] [Abstract][Full Text] [Related]
11. The importance of chromogranin A in the development and function of endocrine pancreas. Portela-Gomes GM; Gayen JR; Grimelius L; Stridsberg M; Mahata SK Regul Pept; 2008 Nov; 151(1-3):19-25. PubMed ID: 18722481 [TBL] [Abstract][Full Text] [Related]
12. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study]. Eberlein-Gonska M; Wiedenmann B; Waldherr R Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534 [No Abstract] [Full Text] [Related]
13. Synaptophysin. A new marker for pancreatic neuroendocrine tumors. Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of chromogranin A in endocrine organs of the rat and horse by use of region-specific antibodies. Hashimoto Y; Ohki H; Sato F; Yanaihara N; Iwanaga T Jpn J Vet Res; 2001 May; 49(1):3-17. PubMed ID: 11521446 [TBL] [Abstract][Full Text] [Related]
15. Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs. Hawkins KL; Summers BA; Kuhajda FP; Smith CA Vet Pathol; 1987 Mar; 24(2):170-9. PubMed ID: 2883753 [TBL] [Abstract][Full Text] [Related]
16. Insulin-secreting tumor: diagnosis and medical and surgical management in 55 dogs. Leifer CE; Peterson ME; Matus RE J Am Vet Med Assoc; 1986 Jan; 188(1):60-4. PubMed ID: 3003016 [TBL] [Abstract][Full Text] [Related]
17. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194 [TBL] [Abstract][Full Text] [Related]
18. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency. Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646 [TBL] [Abstract][Full Text] [Related]
19. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study. Jirásek T; Hozák P; Mandys V Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271 [TBL] [Abstract][Full Text] [Related]
20. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas. de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]